New Key Statistics Module, Z-Score and F-Score
SZSE:002898 Key Ratios
Market Cap ¥ M | 1,561.12 |
Enterprise Value ¥ M | 1,741.60 |
P/E(ttm) | 184.79 |
PE Ratio without NRI | 443.50 |
Forward PE Ratio | -- |
Price/Book | 2.92 |
Price/Sales | 5.04 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 1.00 |
Revenue (TTM) ¥ M | 309.00 |
EPS (TTM) ¥ | 0.05 |
Beneish M-Score | -2.11 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 73.28 |
EV-to-EBITDA | 73.28 |
PEG | -- |
Shares Outstanding M | 176.00 |
Net Margin (%) | 2.68 |
Operating Margin % | 6.79 |
Pre-tax Margin (%) | 5.59 |
Quick Ratio | 0.74 |
Current Ratio | 1.11 |
ROA % (ttm) | 1.02 |
ROE % (ttm) | 1.56 |
ROIC % (ttm) | 1.45 |
Dividend Yield % | 0.22 |
Altman Z-Score | 4.07 |
SZSE:002898 Number of Guru Trades
SZSE:002898 Volume of Guru Trades
Gurus Latest Trades with SZSE:002898
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002898 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sailong Pharmaceutical Group Co Ltd Insider Transactions
No Available Data